An update on the treatment of canine atopic dermatitis

Rosanna MarsellaDepartment of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida Gainesville, FL, USAAbstract: Remarkable progress has been made in recent years concerning our understanding of the pathogenesis of canine atopic dermatitis (AD). As our understanding...

Full description

Bibliographic Details
Main Author: Marsella R
Format: Article
Language:English
Published: Dove Medical Press 2012-08-01
Series:Veterinary Medicine : Research and Reports
Online Access:http://www.dovepress.com/an-update-on-the-treatment-of-canine-atopic-dermatitis-a10858
id doaj-3ff034fe8f3d475b9cf9452cd7b5c192
record_format Article
spelling doaj-3ff034fe8f3d475b9cf9452cd7b5c1922020-11-25T02:26:50ZengDove Medical PressVeterinary Medicine : Research and Reports2230-20342012-08-012012default8591An update on the treatment of canine atopic dermatitisMarsella RRosanna MarsellaDepartment of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida Gainesville, FL, USAAbstract: Remarkable progress has been made in recent years concerning our understanding of the pathogenesis of canine atopic dermatitis (AD). As our understanding improves, the therapeutic approach evolves. Of utmost importance is the documentation of skin barrier impairment in canine AD: ceramides deficiency leads to increased permeability and increased allergen penetration and sensitization. It is currently unknown whether this dysfunction is primary and genetically inherited or secondary to inflammation but it is accepted that skin barrier deficiency plays an important role in either starting or minimally exacerbating canine AD. Thus, the therapeutic approach has changed from focusing on the control of the inflammation to a combined approach that includes therapies aimed at skin barrier repair. The issue of skin barrier repair has been addressed both with oral administration of essential fatty acids and the topical application of products containing a combination of ceramides and fatty acids. These strategies are most helpful as adjunctive treatments and would be best used in young patients that have not developed chronic skin changes. Importantly, treatment for canine AD is multimodal and tailored to the individual patient, the age, and the duration of the disease. Client education plays an important role in explaining the importance of a long-term approach to minimize flare-ups and, in this context, topical therapy to correct skin barrier can be of great benefit. This is an area still in infancy and much work is needed to identify the best formulation. In human medicine, long-term use of moisturizers can have a profound effect on skin barrier and gene expression of proteins involved in skin barrier. This effect is variable depending on the formulation used. It is reasonable to speculate that the same may be true in dogs; thus, it is very important to identify the correct ingredients and formulation to use.Keywords: dogs, atopic dermatitis, treatment, skin barrier repairhttp://www.dovepress.com/an-update-on-the-treatment-of-canine-atopic-dermatitis-a10858
collection DOAJ
language English
format Article
sources DOAJ
author Marsella R
spellingShingle Marsella R
An update on the treatment of canine atopic dermatitis
Veterinary Medicine : Research and Reports
author_facet Marsella R
author_sort Marsella R
title An update on the treatment of canine atopic dermatitis
title_short An update on the treatment of canine atopic dermatitis
title_full An update on the treatment of canine atopic dermatitis
title_fullStr An update on the treatment of canine atopic dermatitis
title_full_unstemmed An update on the treatment of canine atopic dermatitis
title_sort update on the treatment of canine atopic dermatitis
publisher Dove Medical Press
series Veterinary Medicine : Research and Reports
issn 2230-2034
publishDate 2012-08-01
description Rosanna MarsellaDepartment of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida Gainesville, FL, USAAbstract: Remarkable progress has been made in recent years concerning our understanding of the pathogenesis of canine atopic dermatitis (AD). As our understanding improves, the therapeutic approach evolves. Of utmost importance is the documentation of skin barrier impairment in canine AD: ceramides deficiency leads to increased permeability and increased allergen penetration and sensitization. It is currently unknown whether this dysfunction is primary and genetically inherited or secondary to inflammation but it is accepted that skin barrier deficiency plays an important role in either starting or minimally exacerbating canine AD. Thus, the therapeutic approach has changed from focusing on the control of the inflammation to a combined approach that includes therapies aimed at skin barrier repair. The issue of skin barrier repair has been addressed both with oral administration of essential fatty acids and the topical application of products containing a combination of ceramides and fatty acids. These strategies are most helpful as adjunctive treatments and would be best used in young patients that have not developed chronic skin changes. Importantly, treatment for canine AD is multimodal and tailored to the individual patient, the age, and the duration of the disease. Client education plays an important role in explaining the importance of a long-term approach to minimize flare-ups and, in this context, topical therapy to correct skin barrier can be of great benefit. This is an area still in infancy and much work is needed to identify the best formulation. In human medicine, long-term use of moisturizers can have a profound effect on skin barrier and gene expression of proteins involved in skin barrier. This effect is variable depending on the formulation used. It is reasonable to speculate that the same may be true in dogs; thus, it is very important to identify the correct ingredients and formulation to use.Keywords: dogs, atopic dermatitis, treatment, skin barrier repair
url http://www.dovepress.com/an-update-on-the-treatment-of-canine-atopic-dermatitis-a10858
work_keys_str_mv AT marsellar anupdateonthetreatmentofcanineatopicdermatitis
AT marsellar updateonthetreatmentofcanineatopicdermatitis
_version_ 1724845341642063872